|
US20020037876A1
(en)
*
|
1998-06-25 |
2002-03-28 |
Yissum Research Development Company Of Hebrew University Of Jerusalem |
Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
|
MXPA01009893A
(es)
|
1999-04-01 |
2003-07-28 |
Esperion Therapeutics Inc |
Compuestos con eter, composiciones y usos de estos.
|
|
WO2002009691A1
(en)
*
|
2000-08-02 |
2002-02-07 |
Pharmanutrients |
Methods and compositions for the prevention and treatment of syndrome x
|
|
WO2002024227A1
(en)
*
|
2000-09-20 |
2002-03-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Tumor cell proliferation inhibitors
|
|
AU2002211666A1
(en)
|
2000-10-11 |
2002-04-22 |
Esperion Therapeutics, Inc. |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
MXPA03003024A
(es)
|
2000-10-11 |
2003-07-14 |
Esperion Therapeutics Inc |
Compuestos de sulfoxido y bis-sulfoxido y composiciones para el control de colesterol y usos relacionados.
|
|
IL155215A0
(en)
|
2000-10-11 |
2003-11-23 |
Esperion Therapeutics Inc |
Ether compounds and compositions for cholesterol management and related uses
|
|
WO2002030860A2
(en)
|
2000-10-11 |
2002-04-18 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
US7304093B2
(en)
|
2000-10-11 |
2007-12-04 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
NO20006008L
(no)
*
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
AU2003223930A1
(en)
*
|
2002-06-14 |
2003-12-31 |
Novo Nordisk A/S |
Pharmaceutical use of boronic acids and esters thereof
|
|
HUE036646T2
(hu)
|
2003-01-23 |
2018-07-30 |
Esperion Therapeutics Inc |
Hidroxilvegyületek és kompozícióik koleszterin szabályozására és kapcsolódó alkalmazásokra
|
|
JP2007525408A
(ja)
|
2003-12-24 |
2007-09-06 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロール管理および関連使用のためのケトン化合物および組成物
|
|
WO2005062718A2
(en)
*
|
2003-12-30 |
2005-07-14 |
Syndromex Ltd. |
Methods of administering 3,3,14,14 tetramethyl hexadecane 1,16 dioic acid
|
|
KR20050118057A
(ko)
*
|
2004-04-24 |
2005-12-15 |
김상희 |
아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
|
|
CA2617213C
(en)
|
2005-07-29 |
2014-01-28 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
WO2007137864A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Eucro European Contract Research Gmbh & Co. Kg |
Use of inhibitors of pp2c for treating or preventing arteriosclerosis
|
|
US7777071B2
(en)
|
2006-08-11 |
2010-08-17 |
Ssv Therapeutics, Inc. |
Production of carnitine conjugate intermediates
|
|
WO2008092231A1
(en)
|
2007-02-01 |
2008-08-07 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular diseases
|
|
IL181577A0
(en)
*
|
2007-02-26 |
2007-07-04 |
Jacob Bar Tana |
Combination therapy composition and methods for the treatment of cardiovascular disorders and immune-related disorders
|
|
EP2167069B1
(en)
|
2007-05-23 |
2011-10-26 |
Amcol International Corporation |
Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
|
|
DE102007051339A1
(de)
*
|
2007-10-26 |
2009-04-30 |
Müller-Enoch, Dieter, Prof. Dr. |
Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
|
|
EP2085082A1
(en)
*
|
2008-01-29 |
2009-08-05 |
Nutromnia S.R.L. |
Treatment of cognitive decline
|
|
KR101629356B1
(ko)
|
2008-06-26 |
2016-06-13 |
리스버로직스 코퍼레이션 |
퀴나졸리논 유도체의 제조방법
|
|
AU2010204106B2
(en)
|
2009-01-08 |
2014-05-08 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|
|
US10478464B2
(en)
*
|
2009-01-14 |
2019-11-19 |
Kirit Shah |
Compositions and methods of use
|
|
NZ755378A
(en)
|
2009-03-18 |
2022-07-29 |
Resverlogix Corp |
Novel quinazolinones and related compounds for use as anti-inflammatory agents
|
|
WO2010120534A1
(en)
*
|
2009-03-31 |
2010-10-21 |
Whitten Matthew R |
System and method for radiation therapy treatment planning using a memetic optimization algorithm
|
|
KR20190091564A
(ko)
|
2009-04-22 |
2019-08-06 |
리스버로직스 코퍼레이션 |
신규한 소염제
|
|
PE20161551A1
(es)
|
2009-09-03 |
2017-01-18 |
Pfizer Vaccines Llc |
Vacuna de pcsk9
|
|
US20140004142A1
(en)
|
2011-03-02 |
2014-01-02 |
Pfizer Inc. |
Pcsk9 vaccine
|
|
RU2640115C2
(ru)
|
2011-11-01 |
2017-12-26 |
Ресверлоджикс Корп. |
Фармацевтические композиции замещенных хиназолинонов
|
|
WO2013084237A1
(en)
*
|
2011-12-08 |
2013-06-13 |
Syndromex Ltd. |
Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
AU2013365926B9
(en)
|
2012-12-21 |
2019-01-17 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2015123291A1
(en)
|
2014-02-11 |
2015-08-20 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Pcsk9 vaccine and methods of using the same
|
|
RU2022102472A
(ru)
|
2015-03-13 |
2022-03-15 |
Эсперион Терапеутикс, Инк. |
Фиксированные комбинации и составы, содержащие etc-1002 и эзетимиб, и способы лечения или уменьшения риска развития сердечно-сосудистого заболевания
|
|
JO3789B1
(ar)
|
2015-03-13 |
2021-01-31 |
Resverlogix Corp |
التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة
|
|
MA41793A
(fr)
|
2015-03-16 |
2018-01-23 |
Esperion Therapeutics Inc |
Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
|
|
US20180092874A1
(en)
*
|
2016-10-03 |
2018-04-05 |
Lincoln Memorial University |
Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
|
|
WO2019010414A1
(en)
*
|
2017-07-07 |
2019-01-10 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Fatty acid derivatives and their use
|
|
CN112437766A
(zh)
|
2019-06-21 |
2021-03-02 |
艾斯柏伦治疗公司 |
制备贝派地酸及其组合物的方法
|